members (A) In general Ten additional members shall be appointed to the Committee by the Comptroller General of the United States not later than 180 days after the date of enactment of this Act. Such members shall include— (i) 2 patient and consumer representatives not affiliated with any organization that receives funding from pharmaceutical manufacturers